Member Info for desamax

Free registration for live stream from endpoint, might be something, might be nothing.

https://jpm23.endpts.com/?source=eblast20230108

Some company presentations will be available on their individual websites.
Will Sareum be putting there’s up ??

Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/a0f74126-755d-487c-b65c-51d21124fec0

UK government is partnering with German Covid-19 vaccine maker BioNTech to enrol up to 10,000 patients in clinical trials for cutting-edge cancer treatments.

BioNTech, which partnered with US pharmaceutical group Pfizer to develop a Covid jab that was the world’s bestselling by revenue, said on Friday that it would open a research and development centre with 75 staff in Cambridge.

It added that it would open an office in London at the same time, and may later consider investing in manufacturing in the UK.

Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/a0f74126-755d-487c-b65c-51d21124fec0

The company is developing personalised cancer vaccines, which it hopes will harness patients’ immune systems to tackle their tumours. The so-called vaccines are tailored to an individual tumour’s genetic code.

Ugur Sahin, BioNTech’s co-founder and chief executive, said the investment to meet the pledge of enrolling 10,000 patients by 2030 would be “huge” but that he could not yet put an exact number on it.

Steve Barclay, the health secretary, said UK patients could possibly participate in the trial from as early as September.

“This agreement builds on this government’s promise to increase research and development spending to £20bn per year,” he said, adding that it “demonstrates the UK remains one of the most attractive places in the world for innovative companies to invest in research”.

The UK last year signed a £1bn deal with Moderna, another Covid vaccine maker, to establish the first manufacturing centre for shots using messengerRNA, which teaches the immune system to recognise pathogens through a genetic code.

Özlem Türeci, BioNTech’s co-founder and chief medical officer, said the UK was an “obvious” choice for the clinical trials because of its “exceptionally agile” regulator, the NHS’s ability to recruit participants and its expertise in genomics.

https://www.ft.com/content/a0f74126-755d-487c-b65c-51d21124fec0

That’s a good enough reason for the likes of me to add more, thanks Adam

https://www.jpmorgan.com/solutions/cib/insights/health-care-conference

Our Chairman Stephen Parker will be attending the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, from 9-12 January. 

At Sareum Ltd we are focused on advancing our internal programmes on distinct dual tyrosine kinase 2 (#TYK2) / Janus kinase 1 (#JAK1) inhibitors into clinical development as potential new therapies for autoimmune diseases, respiratory symptoms arising from viral infections and cancer immunotherapy.

Stephen would be delighted to meet anyone who would like to learn more about Sareum, so please get in contact if you would like to meet with him.

#JPM2023 #Conference #Healthcare

Questoon:
Does serria/GSK have to hand over all the patent data with sra737? Is this set in stone that the data come with the return

On here, looking forward to some news in the next 12 days.

Gropelad you wished ha ha it was .. 30 ish when you ramped boil. As if anyone listen to a prover porkie teller.
“The unexpected bonus is getting out for a while and picking up some baron oil (boil) recoup losses. Big announcement on or before 26th”
You said that on the 20th a look what happen. Your locked in there and here great bit of trading that lad Lol.

Aber he was ramping boil the other week @ ..35 it’s now around..12 -..15 that says it all about him and what he knows.

Grovelad it could be because they all piled into BoIL after you ramped it a ..35 what’s it now? ..12ish lol

Taken from the latest Edison report..
“ The magnitude of the issue and what exactly the MHRA observations relate to is unclear. Sareum is in talks with the MHRA to seek further information and will be updating the market on subsequent developments. The company had planned to initiate the Phase Ia trial (safety and dose-finding study in healthy volunteers) in Q422 which, in our opinion, is now likely to be delayed until 2023 at the earliest.”

It seems everyone is in The dark.

Silver, Gropelad was here to tell us to buy baron oil @ .35 now over 50% down , no wonder he is angry but can’t take it out on himself so comes here to vent.

That can only be Gropelad

Where’s WIP anyone had contact ?

Gropelad is upset that boil has turned into a carbuncle on his bottom. .32 down to .16 so far. He sure knows how to pick ‘em.

Can this be viewed anywhere?

Would anyone have any idea of the time scale rot the 1a trial?

On that link scroll down and click on the Sareum interview